PIGA, ISABELLA
 Distribuzione geografica
Continente #
NA - Nord America 8.170
AS - Asia 6.233
EU - Europa 4.962
SA - Sud America 904
AF - Africa 151
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 2
Totale 20.439
Nazione #
US - Stati Uniti d'America 7.917
SG - Singapore 1.883
IT - Italia 1.483
CN - Cina 1.301
VN - Vietnam 1.230
HK - Hong Kong 838
DE - Germania 705
BR - Brasile 680
RU - Federazione Russa 638
IE - Irlanda 520
SE - Svezia 455
GB - Regno Unito 279
IN - India 200
FR - Francia 194
CA - Canada 154
AT - Austria 129
KR - Corea 105
UA - Ucraina 105
ID - Indonesia 102
BD - Bangladesh 100
FI - Finlandia 93
AR - Argentina 81
NL - Olanda 74
ES - Italia 67
JP - Giappone 65
PL - Polonia 59
MX - Messico 58
TR - Turchia 58
ZA - Sudafrica 58
IQ - Iraq 55
DK - Danimarca 40
PH - Filippine 39
PK - Pakistan 38
EC - Ecuador 33
SA - Arabia Saudita 32
CO - Colombia 29
CH - Svizzera 24
MA - Marocco 24
LT - Lituania 22
VE - Venezuela 22
PY - Paraguay 21
AU - Australia 17
IR - Iran 17
MY - Malesia 17
TW - Taiwan 17
UZ - Uzbekistan 17
BE - Belgio 16
EG - Egitto 12
KE - Kenya 12
LB - Libano 12
OM - Oman 12
TN - Tunisia 12
UY - Uruguay 12
CL - Cile 11
IL - Israele 11
TH - Thailandia 11
ET - Etiopia 9
KZ - Kazakistan 9
PE - Perù 9
CZ - Repubblica Ceca 8
JO - Giordania 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
CR - Costa Rica 7
DO - Repubblica Dominicana 7
BO - Bolivia 6
DZ - Algeria 6
JM - Giamaica 6
SY - Repubblica araba siriana 6
AL - Albania 5
BG - Bulgaria 5
KG - Kirghizistan 5
LV - Lettonia 5
NP - Nepal 5
PA - Panama 5
PS - Palestinian Territory 5
PT - Portogallo 5
RO - Romania 5
GR - Grecia 4
HN - Honduras 4
KW - Kuwait 4
RS - Serbia 4
TT - Trinidad e Tobago 4
AM - Armenia 3
GA - Gabon 3
HR - Croazia 3
BH - Bahrain 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
GE - Georgia 2
GT - Guatemala 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MN - Mongolia 2
MT - Malta 2
MU - Mauritius 2
NG - Nigeria 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 20.413
Città #
Ann Arbor 1.300
Singapore 1.100
Hong Kong 806
Ashburn 768
San Jose 682
Milan 588
Dublin 508
Frankfurt am Main 493
Chandler 458
Fairfield 351
Ho Chi Minh City 329
Wilmington 311
Hanoi 301
New York 257
Dallas 215
Dearborn 208
Santa Clara 205
Los Angeles 199
Beijing 176
Woodbridge 157
Seattle 146
Chicago 140
Houston 139
Cambridge 138
Princeton 135
The Dalles 129
Hefei 126
Shanghai 121
Dong Ket 116
Seoul 98
Vienna 87
São Paulo 82
Lauterbourg 77
Nanjing 73
Moscow 67
Jakarta 65
Council Bluffs 60
Helsinki 57
Orem 55
Buffalo 49
Kent 48
Montreal 48
Munich 48
Jacksonville 47
Tokyo 47
Da Nang 46
London 44
Nuremberg 43
Warsaw 41
Denver 39
Toronto 39
Brooklyn 38
Chennai 35
Guangzhou 32
Haiphong 28
Lawrence 28
Nanchang 28
Hải Dương 27
Altamura 26
Amsterdam 26
Cagliari 26
Changsha 26
Madison 26
Poplar 26
Caronno Pertusella 25
Shenyang 25
Basingstoke 24
Fremont 24
Florence 23
Rome 23
Johannesburg 22
Ottawa 22
Ha Long 21
Lissone 21
Manchester 21
Baghdad 20
Hebei 20
Zhengzhou 20
Mumbai 19
Rio de Janeiro 19
San Diego 19
San Francisco 19
Stockholm 19
Tianjin 19
Biên Hòa 18
Jinan 18
Lappeenranta 18
Phoenix 18
Andover 17
Atlanta 17
Cinisello Balsamo 17
Pavia 17
Quận Bình Thạnh 17
Tashkent 16
Belo Horizonte 15
Lahore 15
Paris 15
Salt Lake City 15
Turku 15
Boston 14
Totale 12.921
Nome #
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 580
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 541
In-Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 532
Cytological Cytospin Preparation for the Spatial Proteomics Analysis of Thyroid Nodules Using MALDI-MSI 460
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 448
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades 439
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 400
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 386
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 369
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 363
Analysis of Hashimoto's thyroiditis on fine needle aspiration samples by MALDI-Imaging 360
Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry 357
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 355
MALDI-MSI as a Complementary Diagnostic Tool in Cytopathology: A Pilot Study for the Characterization of Thyroid Nodules 351
Matrix-assisted laser desorption/ionisation mass spectrometry imaging in the study of gastric cancer: A mini review 346
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 345
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 342
Molecular trait of follicular-patterned thyroid neoplasms defined by MALDI-imaging 318
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 304
The journey towards clinical adoption of MALDI-MS-based imaging proteomics: from current challenges to future expectations 299
Cytomolecular Classification of Thyroid Nodules Using Fine-Needle Washes Aspiration Biopsies 296
Unsupervised neural networks as a support tool for pathology diagnosis in MALDI-MSI experiments: A case study on thyroid biopsies 293
A molecular imaging approach to individuate tumour infiltrating lymphocytes 279
Spatially Resolved Molecular Approaches for the Characterisation of Non-Invasive Follicular Tumours with Papillary-like Features (NIFTPs) 266
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 262
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model 260
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 255
Mapping the distribution of bioactive compounds and aroma/flavour precursors in green coffee beans with an integrated mass spectrometry-based approach 252
Proteomics tools and mass spectometry imaging techiques for the molecular characterization of pancreas 251
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma 246
Lights on HBME-1: the elusive biomarker in thyroid cancer pathology 246
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 238
Update on: proteome analysis in thyroid pathology - part II: overview of technical and clinical enhancement of proteomic investigation of the thyroid lesions 238
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 237
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 231
Generation of a spectral library for DIA proteomics analysis and application to serum samples using TIMS-TOF MS/MS 228
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 224
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 223
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 223
Total and synaptoproteomic changes underlying response/non-response to the rapid antidepressant effect of ketamine in the hippocampus of a preclinical model of depression. 221
6-Aza-2-Thiothymine as an Alternative Matrix for Spatial Proteomics with MALDI-MSI 215
Putative salivary biomarkers useful to differentiate patients with fibromyalgia 215
Pathology Laboratory Archives: Conservation Quality of Nucleic Acids and Proteins for NSCLC Molecular Testing 207
Exploring 6-aza-2-Thiothymine as a MALDI-MSI Matrix for Spatial Lipidomics of Formalin-Fixed Paraffin-Embedded Clinical Samples 201
Ultra-high resolution MALDI-FTICR-MSI analysis of intact proteins in mouse and human pancreas tissue 201
New insights in lipids MALDI MS imaging in FFPE tissue: Antigen retrieval and its effect on positive ion species 201
Progress in clinical applications for the MALDI-imaging analysis of thyroid fine needle aspiration biopsies: evaluation of proteomic stability in preservative solutions 198
The evolving landscape of diagnostic pathology: a step towards the integration of MALDI-MSI for the routine diagnosis of thyroid fine needle aspiration biopsies 192
Progress in clinical applications for the MALDI-Imaging analysis of thyroid biopsies: evaluation of proteomic stability in preservative solutions 180
Ultra-high resolution MALDI-FTICR-MSI analysis of intact proteins in mouse and human pancreas tissue 179
Data analysis optimisation of a DIA-PASEF mass spectrometry approach for the study of idiopathic membranous nephropathy disease 178
The management of haemoglobin interference for the MALDI-MSI analysis of in-vivo thyroid biopsies 178
Glucagon-like peptide 1 protects INS-1E mitochondria against palmitate-mediated beta-cell dysfunction: A proteomic study 178
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 177
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 176
Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology 170
Influence of sampling on the determination of warfarin and warfarin alcohols in oral fluid 170
MALDI-MSI as complementary tool in the characterization of thyroid nodules: novelties and challenges in the evolving landscape of diagnostic pathology 166
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 165
Recent advances in MALDI mass spectrometry imaging: a cutting edge tool for the diagnosis of thyroid nodules 160
Towards a standardised protocol for proteomic analysis of thyroid fine-needle-aspiration biopsies by MALDI-MSI: Management of haemoglobin interference 157
C0513: A Non-Invasive Approach for Monitoring Patients Undergoing Anticoagulant Therapy 157
Strumentazione, preparazione del campione, deposito matrice, impostazione e lancio esperimento 157
Tri-modal MALDI-MS imaging on the same tissue section: deeper molecular insights of disease 157
Determination of total and unbound warfarin and warfarin alcohols in human plasma by high performance liquid chromatography with fluorescence detection 155
Biomarker identification through spatial proteomics for the characterization of indeterminate thyroid nodules 154
Does the urinary proteome reflect ccrcc stage and grade progression? 154
Tri-modal MALDI-MS Imaging: new frontiers in diagnostics 153
High resolution MALDI-FTICR-MSI analysis of intact proteins in mouse pancreas tissue 147
Delving deeper into the tissue proteome: improving cell-specificity with high spatial resolution MALDI-MS Imaging 146
Tri-modal MALDI-MS imaging of lipids, N-Glycans, and proteins on a single tissue section 144
Towards lipid MALDI-MS imaging in FFPE tissue: antigen retrieval and its effect on positive ion species 143
Determination of anticoagulant drugs and their metabolites in oral fluid: strategies for sample collection 141
Machine Learning Ensemble Algorithms for Classification of Thyroid Nodules Through Proteomics: Extending the Method of Shapley Values from Binary to Multi-Class Tasks 139
High resolution MALDI-FTICR-MSI analysis of intact proteins in mouse pancreas tissue 139
Development of mass spectrometry imaging methods for the analysis of intact proteins in mouse pancreas tissues by MALDI-TOF-MS and MALDI-FTICR-MS 136
Determination of Warfarin and Warfarin alcohols in oral fluid and plasma samples for monitoring patients undergoing anticoagulant therapy 135
Advances in thyroglobulin measurement: exploring dried blood spot sampling and mass spectrometry for enhanced clinical utility 133
Determination of Warfarin and Warfarin alcohols in saliva and plasma by high performance liquid chromatography with fluorimetric detection 133
Influence of sampling on the measured concentration of Warfarin and Warfarin alcohols in oral fluid 132
Comparative proteomics of native tuscany cultivars of olea europaea: a preliminary study 131
Determination of anticoagulant drugs and their metabolites in oral fluid and plasma samples by HPLC-Fluorimetry 130
Glucagon-like peptide-1 protects INS-1E against palmitatemediated β-cell dysfunction: a proteomic study 128
Elaborazione dei dati analitici: valutazione della qualità e costruzione di immagini molecolari 128
MALDI-MS Imaging Application in Thyroid FNA: Challenges and Perspectives 127
New frontiers in Pathology: MALDI-MS Imaging for diagnosis of thyroid fine needle aspiration biopsies 126
New insights in MSI pathology: a molecular snapshot of thyroid cancer 122
Monitoring of warfarin therapy: Preliminary results from a longitudinal pilot study 119
Strumentazione, preparazione del campione, deposito matrice, impostazione e lancio esperimento 114
Elaborazione dei dati analitici: valutazione della qualità e costruzione di immagini molecolari 102
Recent Advances in MALDI Mass Spectrometry Imaging: A Cutting-Edge Tool for the Diagnosis of Thyroid Nodules 81
Well Begun Is Half Done: The Impact of Pre-Processing in MALDI Mass Spectrometry Imaging Analysis Applied to a Case Study of Thyroid Nodules 75
6-Aza-2-Thiothymine as a Novel Matrix for MALDI-MSI-Based Lipid Profiling in FFPE Samples 71
Elaboration Pipeline for the Management of MALDI-MS Imaging Datasets 66
Functional, synaptoproteomic and structural adaptations underlying sex-dependent traumatic stress susceptibility/resilience in the hippocampus 57
Advances in thyroglobulin measurement: exploring dried blood spot mass spectrometry for enhanced clinical utility 37
Totale 21.097
Categoria #
all - tutte 63.984
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.984


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021348 0 0 0 0 0 0 0 0 0 0 99 249
2021/20221.078 96 98 59 128 60 91 9 60 44 95 115 223
2022/20231.981 219 504 220 162 96 271 21 129 165 34 88 72
2023/20241.632 52 53 78 114 165 447 325 46 130 26 58 138
2024/20253.411 152 277 226 165 278 140 202 95 412 599 308 557
2025/20268.807 1.190 632 757 1.188 1.048 473 1.459 445 728 796 91 0
Totale 21.097